References
Zürcher A, Knabben L, Janka H, Stute P (2022) Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review. Arch Gynecol Obstet. https://doi.org/10.1007/s00404-022-06640-y
Silva FR, Grande AJ, Lacerda Macedo AC, Colonetti T, Rocha MC, Uggioni MLR et al (2021) Meta-analysis of breast cancer risk in levonorgestrel-releasing intrauterine system users. Clin Breast Cancer 21(6):497–508
Romero SA, Young K, Hickey M, Su HI (2020) Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007245.pub4
Ostroot MK, Heslin K, Kram JJF, Tjoe JA, Dorton B (2021) Breast cancer recurrence risk after hormonal contraceptive use in survivors of reproductive age. Eur J Obstet Gynecol Reprod Biol 258:174–178
Conz L, Mota BS, Bahamondes L, Dória MT, Derchain SFM, Rieira R et al (2020) Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis. Acta Obstet Gynecol Scand 99:970–982
Funding
Done.
Author information
Authors and Affiliations
Contributions
CI—project development, data collection, manuscript writing, manuscript editing. IDG—project development, data collection, manuscript writing, manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
Christos Iavazzo declares that he has no conflict of interest. Ioannis D. Gkegkes declares that he has no conflict of interest. Also, the authors have full control of all primary data and agree to allow the Journal to review their data if requested.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Iavazzo, C., Gkegkes, I.D. Is there an association between levonorgestrel-releasing intrauterine system and breast cancer risk?. Arch Gynecol Obstet 308, 1649–1650 (2023). https://doi.org/10.1007/s00404-022-06798-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-022-06798-5